List of works - Kristina Hug

Banks, repositories and registries of stem cell lines in Europe: regulatory and ethical aspects

scientific article published on 10 February 2009

Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues

scientific article

Challenges to Informed Consent in First-In-Human Trials Involving Novel Treatments: A Case Study of Parkinson's Disease

scientific article published in January 2017

Differences between Parkinson's and Huntington's diseases and their role for prioritization of stem cell-based treatments

scientific article

Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects

scientific article

Experimental Stem Cell-Based Therapy in Pediatrics: A Fictional Case Study

Genetically modified organisms: do the benefits outweigh the risks?

scientific article published on January 2008

Motivation to donate or not donate surplus embryos for stem-cell research: literature review

scientific article

Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe?

scientific article

Reply of the Author: Decisions to donate surplus embryos

Research on human-animal entities: ethical and regulatory aspects in Europe

scientific article

Sources of human embryos for stem cell research: ethical problems and their possible solutions

scientific article

The ethics of withdrawal: the case of follow-up from first-in-human clinical trials

scientific article

Therapeutic perspectives of human embryonic stem cell research versus the moral status of a human embryo--does one have to be compromised for the other?

scientific article

Twenty years of human research ethics committees in the Baltic States

scientific article

Understanding voluntariness of consent in first-in-human cell therapy trials

scientific article published on 01 July 2020

Which patient groups should be asked to participate in first-in-human trials of stem-cell-based therapies?

scientific article published on January 1, 2012

Withdrawal from biobank research: considerations and the way forward

scientific article published in December 2012

List of works by Kristina Hug

Banks, repositories and registries of stem cell lines in Europe: regulatory and ethical aspects

Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues

Challenges to Informed Consent in First-In-Human Trials Involving Novel Treatments: A Case Study of Parkinson's Disease

Differences between Parkinson's and Huntington's diseases and their role for prioritization of stem cell-based treatments

Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects

Experimental Stem Cell-Based Therapy in Pediatrics: A Fictional Case Study

Genetically modified organisms: do the benefits outweigh the risks?

Motivation to donate or not donate surplus embryos for stem-cell research: literature review

Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe?

Reply of the Author: Decisions to donate surplus embryos

Research on human-animal entities: ethical and regulatory aspects in Europe

Sources of human embryos for stem cell research: ethical problems and their possible solutions

The ethics of withdrawal: the case of follow-up from first-in-human clinical trials

Therapeutic perspectives of human embryonic stem cell research versus the moral status of a human embryo--does one have to be compromised for the other?

Twenty years of human research ethics committees in the Baltic States

Understanding voluntariness of consent in first-in-human cell therapy trials

Which patient groups should be asked to participate in first-in-human trials of stem-cell-based therapies?

Withdrawal from biobank research: considerations and the way forward